Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures
Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.
How this was made
The 30-second read
Why it matters
The downgrade reflects concerns about input costs and inventory dynamics, which may lead to short‑term sell pressure.
Market read
The target cut could influence CL's price action and may prompt re‑evaluation of other consumer staples with similar cost exposures.
What to watch
Potential pricing power in key markets and upcoming product innovations could offset cost increases.
Background
Analyst coverage updates often precede market moves and can signal revised expectations for earnings and margins.
Ticker impact
Piper Sandler lowered its price target on Colgate-Palmolive to $95, citing higher oil‑related cost pressures and revised 2027 EPS guidance.
Potential downside of 2‑4% over the next week if the target revision is priced in.
The new target is modestly lower and reflects cost headwinds; investors may reassess valuation.
Market effects
Consumer staples may face margin pressure from rising commodity costs.
Emerging‑market exposure could cushion U.S. demand weakness.
Oil price dynamics could affect multiple consumer‑goods companies worldwide.
Counterpoint
The price target cut may be overly cautious if cost pressures are transitory.
Key entities
- Analyst FirmPiper Sandler
Equity research firm providing the revised target and EPS estimate.
- CompanyColgate-Palmolive
Consumer‑goods maker whose stock is the subject of the analyst revision.
